Carbon dioxide laser ablation of basal cell carcinoma with visual guidance by reflectance confocal microscopy: a proof‐of‐principle pilot study
- 19 April 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 174 (6) , 1359-1364
Abstract
Laser ablation is an alternative, nonsurgical treatment modality for low-risk basal cell carcinoma (BCC). However, lack of confirmative tumour destruction or residual tumour presence has been a limiting factor to its adoption. Reflectance confocal microscopy (RCM) provides noninvasive, cellular-level resolution imaging of the skin and is capable of identifying tumour. To evaluate the use of RCM to guide carbon dioxide (CO2 ) laser ablation of BCC, confirm destruction and correlate findings with histology. RCM was used preablation to evaluate for features of BCC. Ablation was performed with a CO2 laser, and the response rapidly assessed using handheld RCM to evaluate for residual tumour. Confirmative pathology was used to verify confocal imaging. Preablation RCM imaging identified tumour with features not identified on normal, surrounding skin. Postablation, RCM documented complete removal of tumour in six cases and residual tumour in two. Histological examination identified the ablated area and confirmed clearance of tumour in the six aforementioned cases and corroborated confocal findings for residual tumour in the other two cases. We report successful treatment of superficial and nodular BCC using CO2 laser ablation augmented by RCM imaging for preablation guidance and verification of tumour removal postablation. Akin to complete circumferential and deep margin control techniques, using RCM helps to map peripheral and deep BCC margins to hone in on areas exhibiting persistent tumour after ablation. CO2 laser ablation visually guided by RCM can help circumvent previously cited limiting factors of laser ablation for tumour destruction by providing cellular-level resolution imaging of tumour and margin assessment in between each laser pass and postablation.Keywords
Funding Information
- National Institutes of Health (R01EB012466)
- National Institute of Biomedical Imaging and Bioengineering (R01EB020029)
This publication has 19 references indexed in Scilit:
- Combined 585 nm pulsed‐dye and 1,064 nm Nd:YAG lasers for the treatment of basal cell carcinomaLasers in Surgery and Medicine, 2013
- Confocal microscopy to guide Erbium:yttrium aluminum garnet laser ablation of basal cell carcinoma: anex vivofeasibility studyJournal of Biomedical Optics, 2013
- Basal Cell Carcinoma. Treatment with Carbon Dioxide Laser VaporizationAdvances in Cancer: Research & Treatment, 2013
- In Vivo Confocal Microscopy for Diagnosis of Melanoma and Basal Cell Carcinoma Using a Two-Step Method: Analysis of 710 Consecutive Clinically Equivocal CasesJournal of Investigative Dermatology, 2012
- Basal Cell CarcinomaArchives of Plastic Surgery, 2012
- Pulsed dye laser as a novel non‐surgical treatment for basal cell carcinomas: Response and follow up 12–21 months after treatmentLasers in Surgery and Medicine, 2011
- The Efficacy of Facial Skin Cancer Treatment with High-Energy Pulsed Neodymium and Nd:YAG LasersPhotomedicine and Laser Surgery, 2009
- Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: A multicenter studyJournal of the American Academy of Dermatology, 2004
- Treatment of Basal Cell Carcinoma with the Pulsed Carbon Dioxide Laser: A Retrospective AnalysisDermatologic Surgery, 2004
- Ultrapulse CO2Used for the Successful Treatment of Basal Cell Carcinomas Found in Patients with Basal Cell Nevus SyndromeDermatologic Surgery, 2002